PRUDENTIAL FINANCIAL INC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$8,058,000
+118.4%
173,911
+14.9%
0.01%
+100.0%
Q1 2019$3,689,000
-35.1%
151,317
-62.8%
0.01%
-40.0%
Q4 2018$5,686,000
+51.7%
406,847
+65.0%
0.01%
+66.7%
Q3 2018$3,749,000
+13.5%
246,627
+25.3%
0.01%
+20.0%
Q2 2018$3,303,000
+2.7%
196,837
-0.1%
0.01%0.0%
Q1 2018$3,216,000
+1132.2%
197,047
+868.0%
0.01%
Q4 2017$261,000
+10.1%
20,357
+5.8%
0.00%
Q3 2017$237,000
+49.1%
19,247
+1.5%
0.00%
Q2 2017$159,000
+2.6%
18,957
+9.1%
0.00%
Q1 2017$155,000
+4.7%
17,377
+3.5%
0.00%
Q4 2016$148,000
+45.1%
16,787
+10.6%
0.00%
Q3 2016$102,000
+100.0%
15,177
+6.5%
0.00%
Q2 2016$51,000
+37.8%
14,257
+12.6%
0.00%
Q1 2016$37,000
-36.2%
12,657
-8.0%
0.00%
Q4 2015$58,000
-7.9%
13,7570.0%0.00%
Q3 2015$63,000
-36.4%
13,7570.0%0.00%
Q2 2015$99,000
-2.9%
13,757
-0.7%
0.00%
Q1 2015$102,000
+92.5%
13,857
+23.1%
0.00%
Q4 2014$53,000
+29.3%
11,257
-0.9%
0.00%
Q3 2014$41,000
-59.4%
11,357
-48.9%
0.00%
Q2 2014$101,000
+90.6%
22,226
+95.7%
0.00%
Q1 2014$53,000
-8.6%
11,357
-1.7%
0.00%
Q4 2013$58,000
-19.4%
11,5570.0%0.00%
Q3 2013$72,000
+44.0%
11,557
+4.5%
0.00%
Q2 2013$50,00011,0570.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders